ClinConnect ClinConnect Logo
Search / Trial NCT06101940

A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China

Launched by HUASHAN HOSPITAL · Oct 20, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Observational

ClinConnect Summary

This is a multicenter-based, prospective, observational study that primarily focuses on the diagnosis and progression of DM1 patients in China. The investigators collect patient data, including basic information, strength evaluations, genetic data, electromyography results, cognitive performance, and MRIs.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18-80 years
  • With enough cognitivie ability to understand the content and sign the informed consent form
  • With CTG repeats \>50 in DMPK gene, revealed by PCR test
  • Exclusion Criteria:
  • Patients with severe mental illness, or severe anxiety and depression
  • With comorbidities such as traumatic brain injury and cranial tumors
  • A history of alcoholism, psychotropic substance abuse, etc.
  • Patients with severe medical conditions and unstable vital signs that cannot tolerate the tests.
  • Female in pregnancy

About Huashan Hospital

Huashan Hospital, affiliated with Fudan University in Shanghai, is a leading medical institution renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, Huashan Hospital leverages its extensive expertise in various medical disciplines to advance the development of new therapies and treatment modalities. The hospital's state-of-the-art facilities and multidisciplinary teams facilitate rigorous clinical investigations, ensuring adherence to ethical standards and regulatory compliance. With a focus on improving patient outcomes, Huashan Hospital actively collaborates with academic and industry partners to drive forward-thinking research initiatives that address critical healthcare challenges.

Locations

Shanghai, , China

Patients applied

0 patients applied

Trial Officials

Chongbo Zhao, PhD

Study Director

Huashan Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported